UK Markets closed

Nanobiotix S.A. (NNBXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
9.100.00 (0.00%)
At close: 03:47PM EDT

Nanobiotix S.A.

60 rue de Wattignies
Paris 75012
33 1 40 26 04 70

Full-time employees100

Key executives

NameTitlePayExercisedYear born
Mr. Laurent Levy Ph.D.Co-Founder, Pres of the Exec. Board & CEO532.46kN/A1973
Ms. Anne-Juliette Hermant M.A.Chief People Officer & Member of Exec. Board311.37kN/A1974
Prof. Para Prasad Ph.D.Co-Founder and Member of Scientific BoardN/AN/A1945
Mr. Earl J. Bergey Ph.d.Co-FounderN/AN/A1955
Mr. Bart Van RhijnCFO & Member of Exec. BoardN/AN/AN/A
Mr. Alain DostieChief Operating OfficerN/AN/AN/A
Ms. Kathryn M. McNeilSr. VP of Investor RelationsN/AN/A1975
Mr. Brandon OwensVP of Strategic Marketing & Corp. CommunicationN/AN/AN/A
Ms. Elsa BorghiHead of Innovation & Drug DiscoveryN/AN/AN/A
Ms. Sarah GaubertHead of Communication & Public Affairs DepartmentN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France.

Corporate governance

Nanobiotix S.A.’s ISS governance QualityScore as of 1 May 2022 is 10. The pillar scores are Audit: 10; Board: 9; Shareholder rights: 9; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.